chr21-44289802-C-G
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_000383.4(AIRE):āc.798C>Gā(p.Pro266Pro) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000228 in 1,612,568 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_000383.4 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AIRE | NM_000383.4 | c.798C>G | p.Pro266Pro | splice_region_variant, synonymous_variant | 6/14 | ENST00000291582.6 | NP_000374.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AIRE | ENST00000291582.6 | c.798C>G | p.Pro266Pro | splice_region_variant, synonymous_variant | 6/14 | 1 | NM_000383.4 | ENSP00000291582.5 | ||
AIRE | ENST00000527919.5 | n.1531C>G | splice_region_variant, non_coding_transcript_exon_variant | 6/14 | 2 | |||||
AIRE | ENST00000530812.5 | n.2548C>G | splice_region_variant, non_coding_transcript_exon_variant | 4/12 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00127 AC: 194AN: 152210Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000299 AC: 74AN: 247326Hom.: 2 AF XY: 0.000178 AC XY: 24AN XY: 135002
GnomAD4 exome AF: 0.000118 AC: 173AN: 1460240Hom.: 1 Cov.: 34 AF XY: 0.000107 AC XY: 78AN XY: 726418
GnomAD4 genome AF: 0.00127 AC: 194AN: 152328Hom.: 1 Cov.: 33 AF XY: 0.00105 AC XY: 78AN XY: 74486
ClinVar
Submissions by phenotype
Polyglandular autoimmune syndrome, type 1 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 21, 2019 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at